重视肝硬化"易被忽视"并发症的诊治  

Pay attention to the diagnosis and treatment of "easily neglected" complications in liver cirrhosis

作　　者：徐京杭[1] 于岩岩[1] 徐小元[1] Xu Jinghang;Yu Yanyan;Xu Xiaoyuan(Department of Infectious Diseases,Peking University First Hospital,Beijing 100034,China)

机构地区：[1]北京大学第一医院感染疾病科,北京100034

出　　处：《中华肝脏病杂志》2024年第6期481-483,共3页Chinese Journal of Hepatology

基　　金："十三五"国家科技重大专项(2017ZX10202202)。

摘　　要：肝硬化并发症的管理是改善肝硬化患者临床结局的重要措施。除了关注腹水、食管胃静脉出血、肝性脑病、肝肾综合征等常见或危急并发症外,也需要关注血小板减少症、门静脉血栓形成等并发症,以期为肝硬化患者提供完整的病情评估和全面的治疗,提高其生活质量、改善其预后。有效白蛋白更有助于预测肝硬化结局,相关概念逐渐被接受,但其检测方法仍有待进一步标准化和商业化。Managing cirrhosis complications is an important measure for improving patients'clinical outcomes.Therefore,in order to provide a complete disease assessment and comprehensive treatment,improve quality of life,and improve the prognosis for patients with cirrhosis,it is necessary to pay attention to complications such as thrombocytopenia and portal vein thrombosis in addition to common or severe complications such as ascites,esophagogastric variceal bleeding,hepatic encephalopathy,and hepatorenal syndrome.The relevant concept that an effective albumin concentration is more helpful in predicting the cirrhosis outcome is gradually being accepted;however,the detection method still needs further standardization and commercialization.

关 键 词：肝硬化 并发症 诊断 治疗 血小板减少症 门静脉血栓形成 有效白蛋白 

分 类 号：R575.2[医药卫生—消化系统]